09 — EBITDA NORMALIZATION
EBITDA Normalization & Profitability Architecture
Target Profitability — Post-Normalization
25% EBITDA
CPA-Reported ≠ M&A-Grade
The single most important concept for any practice owner considering an exit: CPA-reported financials are optimized for tax treatment, not institutional presentation. EBITDA normalization is the process of converting tax-optimized financials into M&A-grade EBITDA that survives Quality of Earnings scrutiny.
Every CPA advises their dental clients to minimize taxable income — that's their job. But the strategies that minimize tax liability (accelerated depreciation, discretionary expense timing, family payroll, personal expenses through the practice) simultaneously suppress the EBITDA figure that determines enterprise value. A practice showing $200K in CPA-reported net income may have $800K+ in M&A-grade EBITDA once proper normalizations are applied. The practice that doesn't understand this gap goes to market with a suppressed EBITDA and receives a proportionally suppressed offer.
The reverse is equally dangerous: a practice that aggressively adds back every possible expense to inflate EBITDA will have those addbacks challenged, rejected, or discounted during QoE. The goal is not to maximize the EBITDA number — it's to present a defensible EBITDA that can survive line-by-line QoE interrogation.
Hard Addbacks vs. Soft Addbacks
The distinction between hard and soft addbacks is the first thing a buyer's QoE team evaluates, and the category determines how much scrutiny each adjustment receives.
Hard Addbacks
Non-cash or non-recurring items that are universally accepted by institutional buyers:
- Depreciation and amortization: Non-cash expense added back to arrive at EBITDA by definition.
- One-time expenses: Litigation costs, buildout costs, equipment purchases that were expensed rather than capitalized, consulting fees for one-time projects. These require documentation proving they are truly non-recurring.
- Debt service retired at close: Interest payments on loans that the seller retires from transaction proceeds. If the debt won't exist post-closing, the payments are legitimate addbacks.
- Non-operating income/expenses: Investment gains or losses, rental income from non-practice property, income from activities unrelated to clinical operations.
Soft Addbacks
Judgment-dependent items that every buyer's QoE team will challenge:
- Owner compensation normalization: The difference between the owner's total compensation (salary + distributions + benefits + personal expenses) and the market-rate cost of replacing their clinical hours with an associate. Always contested.
- Related-party expenses: Payments to family members, entities owned by the seller, or contractors with a personal relationship to the owner. QoE teams assume these are inflated until proven otherwise.
- Above-market rent: If the practice operates in a building owned by the seller and the rent exceeds fair market value, the excess is a soft addback. Requires an independent lease comp analysis.
- Discretionary spending: Meals, travel, vehicles, continuing education beyond clinical requirements. QoE teams require documentation showing these expenses are non-essential to operations.
Critical: Every soft addback must have supporting documentation — tax returns, market rate compensation surveys, independent lease comps, receipts with business justification — or it will be rejected. The burden of proof is on the seller, and QoE teams default to skepticism.
The QoE Tripwires — What Buyers Actually Normalize
The standard CPA addback list — depreciation, amortization, interest, rent — is basic. Every practice owner's CPA knows these. What separates PDA's analysis are the M&A-specific normalizations that most CPAs have never encountered:
Marketing Normalization
If a practice is spending 0.5% of revenue on marketing when the sustainable benchmark for patient acquisition is 2-3%, a buyer will add marketing expense to the pro-forma P&L. The logic: current patient acquisition rates are unsustainable at current spend, so operating expenses are materially understated. The buyer's QoE team will calculate 2-3% of revenue minus current marketing spend and deduct that delta directly from EBITDA. A practice collecting $2M and spending $10K on marketing ($15K short of the 2% floor) loses $15K-$50K in defensible EBITDA before the negotiation even starts. The practice didn't "save money" on marketing — it created a phantom EBITDA inflation that the buyer will correct.
Associate Misclassification and Lab Fee Allocation
Non-standard compensation structures create compliance exposure and EBITDA distortion. Percentage-of-production arrangements without overhead allocation, misclassified 1099 independent contractor relationships (when the associate functions as a W-2 employee), and lab costs absorbed by the practice rather than allocated to the producing provider — each creates a different EBITDA adjustment in QoE. The misclassification issue is particularly dangerous because it creates both a retroactive tax liability and a go-forward cost increase that QoE will apply.
Spousal and Family Payroll
Removing non-working or under-working family members from the payroll ledger. The spouse on payroll for benefits, the college-age child employed during summer, the parent with a consulting agreement — buyers immediately normalize these. Every dollar of non-productive family payroll is a direct EBITDA addback. But it also signals to the buyer that the owner has been optimizing for tax treatment rather than institutional presentation, which increases scrutiny on every other line item.
Phantom PPO Write-Offs
Revenue recorded on the daily production sheet that gets structurally written off at the collection tier due to uncapped fee schedules on PPO contracts. This inflates top-line production while depressing collection rates — a combination that triggers immediate revenue quality scrutiny. QoE teams compare production records to collections by payer to isolate the structural write-off component.
Owner Compensation Normalization
The owner's total compensation — salary, distributions, benefits, personal expenses run through the practice — must be replaced with a market-rate associate cost to reflect what the practice would pay for the clinical hours the owner currently provides.
This is often the single largest EBITDA adjustment and the most frequently contested in QoE. The negotiation hinges on two questions: what is the owner's total compensation, and what would a market-rate associate cost to replace their production?
If the owner takes $600K in total compensation (salary + distributions + benefits + vehicle + CE + personal expenses) and a market-rate associate producing equivalent clinical hours would cost $250K fully loaded, the $350K difference is an EBITDA addback. That addback may represent 30-50% of the practice's total EBITDA — which is why it's contested.
The reverse scenario is equally important: if the owner takes modest compensation ($180K salary, limited distributions) but works 4 clinical days per week, and a market-rate associate for those hours would cost $250K, the $70K shortfall is a negative EBITDA adjustment. The practice is underreporting its true operating cost, and QoE will correct it downward. Practices where the owner works below market rate to inflate apparent profitability will have that profitability reduced during normalization.
Market Rate Team Analysis
PDA benchmarks every staff position's compensation against current market rates across multiple payroll classifications. The analysis covers clinical assistants, hygienists, front office staff, office managers, billing coordinators, and any administrative or clinical support roles.
Over-Market Compensation
Inflates operating expenses and reduces EBITDA. If the practice pays its lead hygienist $55/hour when market rate is $45/hour, the $10/hour premium across 2,000 annual hours is $20,000 in excess expense. Multiplied by a 6x EBITDA multiple, that's $120,000 in enterprise value suppressed by a single compensation decision.
Under-Market Compensation
Creates a different risk: retention and replacement exposure. If the practice pays hygienists $38/hour when the market rate is $45/hour, the buyer will assume that these team members will require market-rate compensation post-closing to prevent attrition. The $7/hour gap across the hygiene department becomes a negative EBITDA adjustment — increasing projected operating costs to market levels.
Optimal Institutional Presentation
Market-rate staffing across all positions. This eliminates both the expense inflation and the retention risk, presenting a staffing cost that the buyer can rely on as sustainable.
The Phantom EBITDA Concept
Revenue and profit that appear real on the P&L but won't survive institutional scrutiny. This is the conceptual framework of James DeLuca's book Phantom EBITDA — the complete forensic methodology for identifying and eliminating phantom profit before it destroys a transaction.
Sources of phantom EBITDA include:
- Non-defensible clinical production: Procedure patterns that deviate significantly from insurance benchmarks, production recorded for procedures that don't convert to collected revenue, or coding patterns that create compliance exposure.
- AR concentrations requiring reserve: Insurance or patient AR aging beyond 90 days, where collection probability drops below 15% and QoE applies a dollar-for-dollar reserve.
- Unsustainably low marketing spend: When current marketing expenditure is below the benchmark for sustainable patient acquisition, the buyer adds the differential as a future operating cost — directly reducing EBITDA.
- Undocumented soft addbacks: Every soft addback without supporting documentation will be rejected by QoE, reducing the defensible EBITDA figure. The practice's "adjusted EBITDA" may show $900K, but if $150K in soft addbacks can't survive documentation review, the defensible number is $750K.
Profitability Benchmarks
25% EBITDA
PDA uses 25% EBITDA as the profitability benchmark for a well-run practice after normalizing owner compensation with associate-equivalent cost. Practices below 25% have identifiable expense optimization opportunities in staffing, facility costs, supply chain, or operating efficiency. Practices above 25% are either exceptionally efficient or have expense timing anomalies (deferred maintenance, under-investment in marketing or staff) that QoE will surface as sustainability concerns.
55-65% Overhead
For general practices, total overhead — all expenses excluding owner compensation — should fall within this range. Overhead above 65% signals operational inefficiency: staffing ratios may be misaligned, facility costs may be above market, or supply costs may reflect poor vendor negotiation. Overhead below 55% may indicate under-investment that creates sustainability risk.
The 25% EBITDA target and the 55-65% overhead range work in concert. A practice with $2M collections, 60% overhead ($1.2M), and an associate-equivalent owner cost of $250K has an operating profit of $550K — a 27.5% EBITDA margin. That's above the 25% benchmark with a healthy overhead ratio. The same practice with 70% overhead ($1.4M) has operating profit of $350K — a 17.5% margin that signals expense optimization opportunity worth $150K+ in EBITDA improvement, or $900K+ in enterprise value at a 6x multiple.
Frequently Asked
Questions
- What is a good EBITDA margin for a dental practice?
- PDA uses 25% EBITDA as the profitability benchmark for a well-run practice after normalizing owner compensation with associate-equivalent cost. Practices below 25% have identifiable expense optimization opportunities. Practices above 25% are either exceptionally efficient or have expense timing anomalies that QoE will surface. The overhead target is 55-65% of collections — overhead above 65% signals operational inefficiency while below 55% may indicate under-investment in staff, marketing, or equipment that creates sustainability risk.
- What is the difference between hard and soft addbacks in dental EBITDA?
- Hard addbacks are universally accepted: depreciation, amortization, one-time expenses, debt service retired at close. Soft addbacks require documentation and are always challenged: owner compensation normalization, related-party expenses, above-market rent, discretionary spending. Every soft addback will be interrogated by a buyer's QoE team and must have supporting documentation — tax returns, market rate comps, lease agreements — or it will be rejected, reducing the defensible EBITDA.
- What is phantom EBITDA in a dental practice?
- Phantom EBITDA is profit that appears real on the P&L but won't survive institutional scrutiny. Sources include non-defensible clinical production (procedure patterns deviating from insurance benchmarks), AR concentrations requiring reserve, marketing spend unsustainably low (creating a future expense obligation the buyer will add back as cost), and soft addbacks without documentation. This concept is the theme of James DeLuca's book Phantom EBITDA — the complete forensic framework for identifying and eliminating phantom profit before it destroys a transaction.
- How do buyers normalize owner compensation in dental practice sales?
- The owner's total compensation — salary, distributions, benefits, personal expenses run through the practice — must be replaced with a market-rate associate cost for the clinical hours the owner currently provides. This is often the single largest EBITDA adjustment and the most frequently contested in QoE. If the owner takes $600K total compensation but a market-rate associate would cost $250K for equivalent production, the $350K difference is an EBITDA addback. However, if the owner takes $180K and works 4 days/week while market rate is $250K, the $70K shortfall reduces EBITDA.
- What EBITDA normalizations do dental practice buyers make that CPAs miss?
- Four common QoE normalizations most CPAs have never encountered: (1) Marketing normalization — if the practice spends 0.5% on marketing when the sustainable benchmark is 2-3%, buyers add the difference as an operating expense, directly reducing EBITDA. (2) Associate misclassification — non-standard compensation structures (percentage-of-production without overhead allocation, 1099 misclassification) create compliance exposure and EBITDA distortion. (3) Spousal/family payroll — non-productive family members on payroll for benefits; every dollar is a direct addback but also signals tax optimization over institutional presentation. (4) Phantom PPO write-offs — structural revenue written off due to PPO contracted rates inflating production while depressing collection rates.
Related Resources
Explore Further
Related from the Blog
The Dental Practice Data Room: What to Build, How to Structure It, and Why Starting 5 Years Early Changes Your Multiple
Most sellers assemble data rooms in 60 days. Here's the forensic-grade folder structure PE buyers actually expect — and why building it early changes your multiple.
The Merry Go Round Tax: What High Turnover Is Really Costing Your Practice
High turnover is not a staffing problem. It is a tax — paid in lost production, eroded patient trust, training drag, and a QoE audit fingerprint that costs you at the multiple.
The Algorithmic Denial Machine: How Payer AI Is Weaponizing Your Radiographs
Insurance payers are deploying pixel-level AI to deny claims at scale. The same weaponization PE firms use during QoE is coming to every claim you submit.
Next Step
See What a Buyer Will Find Before They Do.
A confidential Pre-LOI briefing with Precision Dental Analytics. We identify QoE vulnerabilities, quantify operational opportunity, and model your three-tiered valuation range.
Confidential | No obligation